INTERNATIONAL PATENT: ARTAX BIOPHARMA INC. FILES APPLICATION FOR "COMBINATION OF A CHROMENE DERIVATIVE TCR INHIBITOR AND A TYK2 INHIBITOR"

GENEVA, Dec. 17 -- ARTAX BIOPHARMA INC. (1 Broadway, 14th FloorCambridge, Massachusetts 02142) filed a patent application (PCT/US2025/032041) for "COMBINATION OF A CHROMENE DERIVATIVE TCR INHIBITOR AND A TYK2 INHIBITOR" on Jun 03, 2025. With publication no. WO/2025/255092, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VANDEUSEN, Christopher, Loren (c/o Artax Biopharma Inc.1 Broadway, 14th FloorCambridge, Massachusetts 02142), ARMSTRONG, Rob (c/o Artax Biopharma Inc.1 Broadway, 14th FloorCambridge, Massachusetts 02142), ...